Melatonina Noxarem

Melatonin, the active ingredient in Melatonina Noxarem, is a melatonin receptor agonist presented as an oral formulation for oral use. It helps regulate the circadian rhythm and is used to support sleep onset in adults experiencing insomnia, jet lag, or other sleep disturbances.

GNH USA supplies Melatonina Noxarem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across global markets and providing reliable logistics for timely delivery.

Melatonina Noxarem (melatonin) acts on the melatonin receptor pathway to address sleep‑related conditions.

- Insomnia: reduces sleep latency and improves overall sleep quality. - Jet lag: assists in realigning the circadian rhythm after rapid time‑zone travel. - Shift work disorder: supports sleep initiation for individuals with irregular work schedules.

Melatonin is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Drowsiness or daytime sleepiness - Headache - Dizziness - Nausea or mild gastrointestinal discomfort - Vivid dreams or nightmares - Mild fatigue

Serious or Rare Side Effects: - Allergic reactions such as rash, itching, or swelling - Severe daytime sleepiness affecting alertness - Mood changes including depression or anxiety - Hallucinations or confusion (rare) - Respiratory depression in susceptible individuals

Before using Melatonina Noxarem, consider the following safety measures.

- Medical supervision: use under the guidance of a healthcare professional. - Age restrictions: not recommended for children unless specifically prescribed. - Driving and machinery: avoid operating vehicles or heavy equipment if drowsiness occurs. - Drug interactions: monitor use with other central nervous system depressants. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Melatonin can interact with several medication classes; monitoring is advised.

Major Interactions (Avoid): - Benzodiazepines or other sedatives: may cause excessive sedation. - Anticoagulants (e.g., warfarin): potential alteration of clotting parameters. - Immunosuppressants (e.g., cyclosporine): may affect melatonin metabolism.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): possible increase in serotonergic effects. - Antihypertensive agents: melatonin may modestly lower blood pressure. - Oral contraceptives: may alter hormone levels and melatonin clearance.